These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4110889)

  • 1. Staphylococcal enterotoxin B induced release of macrophage migration inhibition factor from normal lymphocytes.
    Kaplan J
    Cell Immunol; 1972 Feb; 3(2):245-52. PubMed ID: 4110889
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis.
    Remold HG; Katz AB; Haber E; David JR
    Cell Immunol; 1970 May; 1(1):133-45. PubMed ID: 4108779
    [No Abstract]   [Full Text] [Related]  

  • 3. The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.
    Ward PA; Remold HG; David JR
    Cell Immunol; 1970 Jul; 1(2):162-74. PubMed ID: 4108781
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.
    Simon HB; Sheagren JN
    Cell Immunol; 1972 Jun; 4(2):163-74. PubMed ID: 4112849
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of immunoglobulin receptors on lymphocytes in production of MIF in guinea pigs.
    Gościcka T
    Cell Immunol; 1974 Aug; 13(2):207-15. PubMed ID: 4141646
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage migration from an agarose droplet: development of a micromethod for assay of delayed hypersensitivity.
    Harrington JT; Stastny P
    J Immunol; 1973 Mar; 110(3):752-9. PubMed ID: 4120226
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of migration inhibitory factor in the absence of antigen.
    Yoshida T; Janeway CA; Paul WE
    J Immunol; 1972 Aug; 109(2):201-6. PubMed ID: 4114823
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors.
    Pick E; Brostoff J; Krejci J; Turk JL
    Cell Immunol; 1970 May; 1(1):92-109. PubMed ID: 5523577
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte-derived eosinophil chemotactic factor. II. Studies on the mechanism of activation of the precursor substance by immune complexes.
    Torisu M; Yoshida T; Ward PA; Cohen S
    J Immunol; 1973 Nov; 111(5):1450-8. PubMed ID: 4126774
    [No Abstract]   [Full Text] [Related]  

  • 10. Migration inhibitory factor induction by nonspecific mitogenic stimulation of mouse lymphocytes.
    Gadol N; Waldman RH
    J Reticuloendothel Soc; 1973 Oct; 14(4):398-403. PubMed ID: 4584508
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of migration inhibitory factor (MIF) from guinea pig lymphocytes stimulated with concanavalin A.
    Remold HG; David RA; David JR
    J Immunol; 1972 Sep; 109(3):578-86. PubMed ID: 4115544
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP.
    Dumonde DC; Page DA; Matthew M; Wolstencroft RA
    Clin Exp Immunol; 1972 Jan; 10(1):25-47. PubMed ID: 4111694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact sensitivity in vitro: activation of actively allergized lymphocytes by a beryllium complex.
    Jones JM; Amos HE
    Int Arch Allergy Appl Immunol; 1974; 46(2):161-71. PubMed ID: 4206346
    [No Abstract]   [Full Text] [Related]  

  • 14. Migration inhibition of rat peritoneal cells induced by streptococcal mucopeptides. Characteristics of the reaction and properties of the mucopeptide preparations.
    Heymer B; Bültmann B; Schachenmayr W; Spanel R; Haferkamp O; Schmidt WC
    J Immunol; 1973 Dec; 111(6):1743-54. PubMed ID: 4201554
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells.
    Churchill WH; Piessens WF; Sulis CA; David JR
    J Immunol; 1975 Sep; 115(3):781-6. PubMed ID: 50373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allogeneic effect: increased cellular immune and inflammatory responses.
    Elfenbein GJ; Green I; Paul WE
    J Immunol; 1974 Jun; 112(6):2166-75. PubMed ID: 4133079
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.
    David JR; Coyne JA; Rocklin RE; Nathan CF; Remold HG
    Transplant Proc; 1972 Jun; 4(2):241-2. PubMed ID: 4113698
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of cell surface material from peritoneal exudate cells associated with lymphocyte-mediated inhibition of macrophage migration from capillary tubes.
    Dvorak AM; Hammond ME; Dvorak HF; Karnovsky MJ
    Lab Invest; 1972 Dec; 27(6):561-74. PubMed ID: 4118460
    [No Abstract]   [Full Text] [Related]  

  • 19. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
    Shenton BK; Hughes D; Field EJ
    Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.